– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 –
Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
Seeking Alpha / 15 minutes from now 1 Views
Comments